Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC
- DOI
- 10.1136/jitc-2020-001506
- Published
- 2021-03
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2020-001506,
title = {Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC},
author = {Petra Ross-Macdonald and Alice M Walsh and Scott D Chasalow and Ron Ammar and Simon Papillon-Cavanagh and Peter M Szabo and Toni K Choueiri and Mario Sznol and Megan Wind-Rotolo},
year = {2021},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2020-001506},
url = {https://doi.org/10.1136/jitc-2020-001506}
}RIS
TY - JOUR TI - Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC AU - Petra Ross-Macdonald AU - Alice M Walsh AU - Scott D Chasalow AU - Ron Ammar AU - Simon Papillon-Cavanagh AU - Peter M Szabo AU - Toni K Choueiri AU - Mario Sznol AU - Megan Wind-Rotolo PY - 2021 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2020-001506 UR - https://doi.org/10.1136/jitc-2020-001506 ER -
APA
Ross-Macdonald, P., Walsh, A. M., Chasalow, S. D., Ammar, R., Papillon-Cavanagh, S., Szabo, P. M., Choueiri, T. K., Sznol, M., & Wind-Rotolo, M. (2021). Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2020-001506
Source records
- crossref · retrieved 2026-09-26T20:50:11.365Z